Needham & Company Downgrades GW Pharma (GWPH) to Hold, Following Acquisition

February 3, 2021 11:50 AM EST
Get Alerts GWPH Hot Sheet
Price: $217.93 -0.03%

Rating Summary:
    14 Buy, 7 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 17 | Down: 14 | New: 42
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Needham & Company analyst Serge Belanger downgraded GW Pharma (NASDAQ: GWPH) from Buy to Hold.

For an analyst ratings summary and ratings history on GW Pharma click here. For more ratings news on GW Pharma click here.

Shares of GW Pharma closed at $146.25 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

Needham & Company